Anti-PD-1 inhibitor
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Anti-PD-1 inhibitor, covering 2024-08-28 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer [Phase 2]